MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Let’s Talk Medtech

Gaining 'Insight' on Cardiac Insight’s Recent Surge

spaxiax - IMG_May262021at14708PM.jpg
Let’s Talk Medtech spoke with Dave Hadley, Phd, Senior VP of Research & Development of Cardiac Insight, about the company and the exploding ECG market.

Cardiac Insight is seeing a major uptick in ECG screenings. The Seattle, WA-based company reported there was more than a 70% surge in sales of the Cardea 20/20 ECG in 1Q21.

Let’s Talk Medtech recently spoke with Dave Hadley, Phd, Senior VP of Research & Development. He is the inventor of Cardea 20/20, about the surge and recent interest in the ECG market. Dr. Hadley has more than 30 years of hands-on experience blending customer needs with information technology through research and development. 

Cardiac Insight was named a finalist for this year’s Medical Design Excellence Awards.

Click here to access the most recent episode of Let's Talk Medtech. 



Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.